Abstract:Objectives Tissue inhibitor of metalloproteinases-1 (TIMP-1) is considered to play a key role in the development of pulmonary arterial hypertension (PAH). However, the molecular regulatory mechanisms of TIMP-1 in the pulmonary arteries were not very clear, especially in the human pulmonary arterial smooth muscle cells (HPASMCs). This study try to investigate the signalling pathway involved in the regulation of TIMP-1 in HPASMCs stimulated with transforming growth factor (TGF)-β1. Methods Cultured HPASMCs were incubated with different concentrations of TGF-β1 (0, 2.5, 5, 10, 20 or 40 ng/ml) for 24 h, or with 10 ng/ml TGF-β1 for different time (1, 4, 8, 12, 24 or 48 h). Western blot and real-time PCR were employed to detect the protein and mRNA expression of TIMP-1 in HPASMCs, and enzyme-linked immuno sorbent assay (ELISA) was used to detect the secretion of TIMP-1 in the culture medium. Then, the activities of three mitogen-activated protein kinases (MAPK), including extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and c-Jun NH2-terminal kinase (JNK), were respectively inhibited with their specific inhibitors, U0126, SB202190 and SP600125. The protein and mRNA of TIMP-1 were also detected to help distinguishing that which kinase was involved in the regulation of TIMP-1 in HPASMCs induced by TGF-β1. Besides this, mithramycin, a specific inhibitor of Sp1 transcription factor, and curcumin, a specific inhibitor of activator protein-1 (AP-1), were used to block the DNA-binding activity of Sp1 or AP-1 respectively. And electrophoretic mobility shift assay (EMSA), Western blot and real-time PCR were carried out to help confirming that which transcription factor was involved in the regulation of TIMP-1 in HPASMCs. Results Western blot, real-time PCR and ELISA analysis showed that TGF-β1 could time- and dose-dependently enhance the expression and secretion of TIMP-1. Furthermore, TGF-β1 could phosphorylate two kinases of MAPK, ERK1/2 and p38, but not JNK, and the phosphorylation of p38 was weaker compared with ERK1/2. Of these kinases, only the inhibition of ERK 1/2 by U0126 effectively blocked the TGF-β1-induced expression of TIMP-1. Mithramycin also significantly reduced the expression of TIMP-1 via blocking the DNA-binding activity of Sp1. However, the inhibition of AP-1 by curcumin couldn't achieve this result. Additionally, the results of EMSA showed that TGF-β1 could up-regulate the DNA-binding activity of Sp1, and that U0126 and mithramycin could effectively suppressed this activation in a dose-dependent manner. Conclusions TGF-β1 could time- and dose-dependently stimulate the expression and secretion of TIMP-1 in HPASMCs, and ERK1/2 and Sp1 signalling pathways might be involved in these activities.

Tumor Necrosis Factor-Α Regulates Expression of Vascular Endothelial Growth Factor Via JNK and AP-1 Pathway in MCF-7 Cells

Jnk/Ap-1 Pathway is Involved in Tumor Necrosis Factor-Alpha Induced Expression of Vascular Endothelial Growth Factor in Mcf7 Cells

ACTIVATION OF ERK 1/2 AND SP1 MAY CONTRIBUTE TO THE EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 INDUCED BY TRANSFORMING GROWTH FACTOR-β1 IN HUMAN PULMONARY ARTERIAL SMOOTH MUSCLE CELLS

Tumor Necrosis Factor- α Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways

The Matricellular Protein CCN1 Regulates TNF‐α Induced Vascular Endothelial Cell Apoptosis

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro.

The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity

Activation of p38 mitogen-activated protein kinase induced by tumor necrosis factor-α in human pulmonary microvascular endothelial cells

TNF-α Up-Regulates Protein Tyrosine Phosphatase 1B Via NF-kB in HepG2 Cells

Knockout of the Tumor Necrosis Factor a Receptor 1 Gene Can Up-Regulate Erythropoietin Receptor During Myocardial Ischemia-Reperfusion Injury in Mice.

Molecular Mechanisms Underlying the Induction of Vascular Endothelial Growth Factor Expression by Pituitary Tumor Transforming Gene

Expression of MEK-1 in Regulation of Αv Integrin and E-cadherin of MCF-7 Breast Cancer Cells

Tumor Necrosis Factor-Alpha Induces Adhesion Molecule Expression Through the Sphingosine Kinase Pathway.

The mechanisms of tumor necrosis factor α in regulating Krüpple‐like factor 4 expression in SK‐BR‐3 breast cancer cells

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.

RAS AND MEKK1 CO-REGULATE AP-1- AND NF-?B-MEDIATED GENE EXPRESSION IN

[Tnfα Induced IL-8 Production Through P38 MAPK- NF-kB Pathway in Human Hepatocellular Carcinoma Cells].

Cdna Array Analysis of TNF-α-induced Metastasis Related Genes in MCF-7 Cell

Study on the Inhibition of Drug-Resistant Human Breast Cancer Cells with Exogenous Tumor Necrosis Faclor-Α Gene Therapy

Dual Regulation of Tumor Necrosis Factor-Α on Myosin Light Chain Phosphorylation in Vascular Smooth Muscle